Delivery Order SPE2DB20D1100-SPE2DB25FE1G6
Award Date 8/18/25
Potential Completion Date 8/19/25
Potential Value $4.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $4,261.21 by the Defense Logistics Agency (DLA) for the supply of Pegasys 180 mcg/ml vials. The award, issued on July 28, 2025, is a firm fixed price contract with an ultimate completion date of July 29, 2025. This non-set-aside delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- This delivery order, valued at $6,855.38, was awarded to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Pegasys 180 mcg/0.5 mL syringes. The contract is a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and represents a non-set-aside award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order falls under a child contract structure, leveraging the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PEGASYS 180 MCG/ML VIALML pharmaceuticals. The contract has a potential value of $8,220.18 and a completion date of January 26, 2024. This delivery order contract is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through December 31, 2025. The...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical. Valued at $6,706.70, this order is for the supply of 180 mcg/ml vials of PEGASYS to support DLA medical treatment programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required by December 8, 2023. No set-aside designation was applied to this award issued by...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,778.35, is for the delivery of the drug PEGASYS 180 MCG/ML VIALML. This contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp and DLA, valued at $999,999,999.00, which provides comprehensive global...
- This federal contract award, valued at $4,055.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The contract covers the delivery of PEGASYS 180 MCG/ML VIALML, a...
- Amerisourcebergen Drug Corp has received a $6,036.03 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply PEGASYS 180 MCG/ML VIALML pharmaceutical products. As the prime contractor, Amerisourcebergen will deliver the specified medications to DLA from its headquarters in Conshohocken, Pennsylvania by November 17, 2023. No set-aside designation was applied to this award to support DLA's provision of pharmaceuticals and medical supplies for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $5,322.64 firm fixed price delivery order is for the supply of PEGASYS 180 MCG/0.5 ML SYRINGE 0.5ML pharmaceutical products. The contract has a completion date of January 5, 2024. Amerisourcebergen Drug Corp has received numerous federal contract awards to...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $31,361.72 to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed price, non-set-aside delivery order is issued against AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. The delivery order is for pharmaceutical products and...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $4,049.10 to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...